koto_feja/E+ via Getty Images Novocure ( NASDAQ: NVCR ) said it has appointed Moderna ( MRNA ) executive Christoph Brackmann as its next finance chief. Brackmann will join Novocure immediately as a Senior Financial Advisor and will transition to the role of CFO on January 1, 2025. Current CFO, Ashley Cordova, will become the CEO.
Mr. Brackmann joins Novocure from Moderna ( MRNA ), where he served as Senior Vice President of Finance since 2019. More on NovoCure NovoCure: There Is Still More Upside NovoCure's Stock Stagnates Amid Lack Of Progress Beyond GBM Novocure gets FDA approval for its lung cancer treatment Seeking Alpha’s Quant Rating on NovoCure.
